4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-23-058081
SVP of Business Development acquired 7,501 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flowers Lee SVP of Business Development | 2023-12-08 | Option exercise | +7,501 | $0.14 | $1,050 | 118,809 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flowers Lee SVP of Business Development | 2023-12-08 | Option exercise · Stock Option (Right to Buy) | −7,501 | 0 | D: show line 2 in the form |
Loading xslF345X05/doc4.xml…